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INTRODUCTION
Immunomodulation is a phenomenon that is based on the influence of different endogenous and exogenous substances on the function of molecules and cells pertaining to the immune system. Immunomodulators are substances capable of influencing the immune response by either suppressing or enhancing it. The majority of immunomodulators increases or decreases the immune reaction without displaying any specificity towards the antigen. Some substances can display both effects depending on the dose and mode of application (Nesterova, 1999; Tizard and Schubot, 2004) .
The main target cells of immunomodulatory substances are the T and B lymphocytes, monocytes, macrophages and granulocytes. The way in which immunomodulators act on these cells is not always easy to determine. It is considered that the majority causes changes in the structure of cyclic nucleotides: cyclic adenosine monophosphate and cyclic guanosine monophosphate in the cytoplasm of immunocompetent cells (Nesterova, 1999) .
Application of some immunosuppressant substances is important for the remission of auto-reactive conditions, allergic reactions and in the inhibition of rejection of transplanted organs. Procedures and substances which suppress the immune reaction can be classified into two large groups: antigen dependent nonspecific suppressors and antigen dependant specific suppressors (Lake et al., 2001) The techniques used to suppress the activity of immune system cells were mainly based on the application and effects of X-rays or drugs used to inhibit cell division. The immunosuppressive effects of ionizing radiation are based on its effects on nucleic acids, resulting in undesired mutations with potential latent lethal effects on offspring cells. Irradiated cells show an increased rate of peroxide production and subsequent toxic effects (Bethesda, 2001) . The effects of different doses of ionizing radiation on the thymus and other organs can be observed on the basis of histological changes, as well as on the concentrations of some serum cytokines (Coggle, 1981; Mizutani et al., 2002; Tokuda et al., 2004) .
A large number of peptides extracted from the thymus display an immunostimulatory effect. The following hormones were extracted from the thymic cells: thymosine, thymic humoral factor, thymopoietin, thymostimulin and thymulin. These hormones stimulate T-lymphocyte maturation and differentiation, thus enhancing the activity of Th-lymphocytes, release of interleukin-2 (IL-2), as well as the effects of Tc lymphocytes. Thymostimulin improves the production of interferon-g (IFN-g), thymosine boosts resistance to viral infections (Benedikt, 2000; Munno et al., 1995; Wilson, 1999) . There is clear evidence that thymus extract has effects on the function of B lymphocytes (Twomey and Koutab, 1982) . However, the strongest effect of thymus preparations is on the cellular immune response, targeting T lymphocytes including helpers, suppressors, cytotoxic, TK, NK and macrophages. The thymus extract acts upon the production, maturation and activation of T lymphocytes and macrophages, and stimulates the maturation of immature thymocytes (T6 cells) to T3 cells in the bone marrow. Thymus extract extract increases the number of mature T cells and stimulates the functions of T lymphocytes, such as Th (T4) and Ts (Twomey and Koutab, 1982) .
Some of the thymic hormones express positive therapeutic effects, but their application in medicine is still not clear. The most common use of thymic hormones is in the therapy of respiratory disorders, different infections, immunodeficiency disorders, skin disorders, neoplasms, and following some surgical procedures. Barbaroza et al. (2000) have described the use of thymus extract in therapy of different diseases in few animal species (dogs, rabbits and pigs).
MATERIAL AND METHODS
The experiment was carried out on a total of 230 inbred Wistar male rats, 3 months old and 200-300 g body mass. The experimental animals were kept in stable microclimatic conditions at 18 -22 o C, fed standard chew with ad libitum access to water. The rats were allotted into separate polypropylene cages, 5 rats per cage, divided into 4 experimental groups: A and B (80 rats/group) and C (n=40) and K (n=30). At the very start of the study (day zero) blood samples of all experimental animals were taken from the medial eye angle, thereof animals were left to recover for a week before continuing the experiment.
Experimental groups A and B (80 rats/group) were irradiated on the first day of the experiment with 4 Gy and 6 Gy respectively. These groups were divided into two subgroups (A 1 and A 2 ; B 1 and B 2 ) with 40 rats in each subgroup. In order to follow up the immune response to the tetanus toxoid all experimental animals were immunized with the antitetanus vaccine (TETAVAKSAL-T ® , Institute for Immunology and Virusology, Torlak), on the second day of the trial. After two weeks the studied rats were revaccinated. The subgroups A1 and B1 were treated with 0.2 mL/rat saline up to the end of the trial every other day. Subgroups A2 and B2 were treated at the same time intervals with calf thymus extract.
Experimental group C consisted of 40 rats randomly allotted to 4 subgroups (C1-C4). Rats from subgroups C1 and C2 were irradiated with 4 Gy and groups C3 and C4 with 6 Gy, respectively. Thereof, rats from subgroups C1 and C3 were treated with saline 0.2 mL/rat, and rats from groups C2 and C4 with calf thymus extract every second day. Rats from group C were not vaccinated and were considered as the control group for humoral immune response to TTx.
The fourth experimental (control group K) consisted of 30 rats which were not previously irradiated. They were allotted to 3 subgroups (10 rats each), and described as K1, K2 and K3. the second day of the experiment, rats from subgroups K1 and K2 were groups immunized with antitetanus vaccine (TETAVAKSAL-T ® ), in order to follow the humoral immune response to this antigen. After 14 days they were revaccinated. Animals from groups K1 and K3 were treated with saline (0.2 mL/rat), and rats from group K2 were treated every other day with calf thymus extract.
On the fourth day of the experiment blood samples from 10 rats from subgroups A1, A2, B1 and B2 were taken from the medial eye sinus. Thereof, on the 6 th day of the trial the skin thickness of the knee skin fold was measured on both sides of the body. Phytohemagglutinin (PHA) was applied on the right side, and phosphate buffered solution (PBS) on the left side of the body. On the seventh day skin thickness of the knee skin fold was measured once again. The animals were than introduced into ether anesthesia, blood samples from the abdominal aorta were taken and the animals were than humanely euthanized. This treatment was repeated on 10 rats of the above mentioned subgroups in 7 day intervals until the end of the survey.
Blood from the medial eye angle was drawn on days 0 and 14 from animals of the third experimental group C (C1 -C4). On experimental day 28 blood was drawn from the abdominal aorta in ether anesthesia after which they were sacrificed.
The fourth experimental group, the K control group, underwent the following treatment: on day 27, rats of subgroups K1 and K2 received PHA for skin sensitivity testing. On day 28 all animals were introduced into short ether anesthesia, blood was drawn and they were sacrificed.
Rat irradiation Rats were irradiated as to produce immunosuppression. Irradiation was performed by a linear accelerator SLiELEKTRA. The dosage was 4 and 6 Gy at a 5 cm depth, using SSD technique (source to skin distance 100 cm) with an irradiation field 35 x 35 cm. The energy of the rays was 4 MV.
Thymus extract application THYMEX-L (THYMOORGAN-GmbH PHARMAZIE &Co. KG, Germany) was used as an immunostimulator to treat the rats. One vial of this drug contains 150 mg of the total thymus extract THX, according to dr Pesic, isolated from young, fresh, veal thymi, standardized according to protein content. The content of suspended protein is 0.6 mg / mg, at pH 7.1 and 37 o C. Besides immunogenic peptides and proteins, THYMEX-L contains also active adenosinedeaminases, purine nucleoside phosphatases, superoxide dismutase, glutathione reductase, glutathion-S-transferase, glutathione peroxidase and peptidase. One vial of THYMEX-L is dissolved in 2 mL aqua pro injectione. The experimental animals were treated every other day with 0.2 mL of extract for each animal or 9 mg of protein per animal. Exract was administered subcutaneously every other day with the last injection on the 26 th day of the experiment.
Assessment of the cellular immune response
The evaluation of the cellular immune response was monitored by IL-2 and IFN-g ELISA tests. We used commercially prepared module sets for IL-2 DuoSet ® ELISA Development System Rat IL-2 produced by R&D System Inc. Minneapolis USA. We have tested IFN-g concentration in the sera of irradiated rats with ready made rat sets BMS621MST produced by Bender MedSystems GmbH, Vienna, Austria. The results were determined on Behring ELISA processor II apparatus according to the manufacturer's procedure.
Assessment of the humoral immune response
Rats were immunized with a commercial vaccine TETRAVAKSAL-T ® (Institute for immunology and virology Torlak). This vaccine is designed for human use, so that for rat immunization the contents of one vial (0.5 mL) were diluted with 4.5 mL aqua pro injectione. Every rat from groups A, B, K1 and K2 received 0.1 mL intramuscularly and revaccination was carried out after 14 days. Antibody content was determined by ELISA (Simensen et al., 1986; Vos et al., 1979) on a Behring ELISA Processor II (Germany).
Cutaneous hyper-reactivity test (CBHR)
Cutaneous hyper-reactivity was tested injecting intradermally 100 mg of phytohemagglutinin (PHA) in a 0.1 mL solution into the knee skin fold of the rats' right leg. Simultaneously, the same volume of PBS (phosphate buffered solution, pH 7.2) was injected into the left knee skin fold. These tests were carried out on days 0, 6, 13, 20 and 27 of the experiment. The degree of reaction was estimated after 24 hours. The degree of reactivity was calculated from the difference of skin thickness on the right and left sides. Skin thickness was gauged to 0.1 mm accuracy. Changes resulting from the KHO test were calculated using the appropriate formula (Smits et al., 1999; Goto et al., 1978; Graeves and Roitt, 1968) .
Statistical analysis
Statistical analysis was done after mean and standard deviation calculations. Significance was tested using the Student t -test.
RESULTS
Our results are presented in figures 1 to 4. The level statistically significant differences observed between experimental groups of rats during the 28 day testing period is shown in Tables 1 and 2 . K1 rats immunized with antitetanus vaccine on days 2 and 14 and treated with saline (n = 10) K2 rats immunized with antitetanus vaccine on days 2 and 14 and treated with thymus extract (n = 10) K3 non vaccinated rats treated with saline (n = 10)
IL-2 concentration
After a single exposure to 4 or 6 Gy of ionizing radiation, all experimental animals had a reduction of IL-2 concentration in sera on the fourth day averaging 45% compared to levels before irradiation ( Figure 1 ). Further follow up showed a gradual increase of IL-2 mean concentrations in the rat sera. In the A1 subgroup (rats irradiated with 4 Gy), IL-2 concentrations rose by the seventh day, and this increase was evident until the end of the experiment, but for a reduction on day 11. The highest concentration was recorded on day 21.
In B1 subgroup, in which rats were irradiated with 6 Gy, only smaller oscillations of mean IL-2 concentratios were registered during the experiment. The highest concentration was measured on day 18 but we didn't observe a tendency of elevation as in group A1.
Comparing the mean concentrations of IL-2 between groups A1 and B1 statistically significant differences were noted on day 11 at a p £ 0.05 level, and then on day 21 at a level of significance of p £ 0.01 in favor of group A1.
In rats irradiated with single dose of 4 or 6 Gy that were treated with bovine thymus extracts, there was a gradual increase of IL-2 concentrations in sera from day 7, until the end of the experiment. The highest concentration of IL-2 in sera of rats recieving 4 Gy dose and subsequentily recieving the extract, the highest concentration was achieved on day 21. This difference has a high statistical significance (p £ 0.001) compared to concentrations on day 4 of the experiment. After that, we noted a slight decrease of IL-2 concentration, but on day 21 they were still significantly higher than on day 4 (p £ 0.01).
Comparing IL-2 concentrations in the subgroup treated with bovine thymus extract with the levels in the subgroup that was not treated, from day 11 there are statistically significant differences in group A, and from day 21 in group B. The subgroups that were treated with thymic extract after irradiation had higher concentrations of IL-2 in sera. The concentrations in subgroup B2 were lower than in subgroup A2 and the difference was statistically significant on days 21 and 28 (p £ 0.05) and highly significant (p £ 0.01) on day 25 (Table 1) .
IFN-g concentration
On the fourth day after a single dose irradiation of the experimental animals with 4 or 6 Gy, all individuals had a decrease of IFN-g concentrations in sera (Figure 2 ). In the subgroup A1 the fall was by 17%, and in subgroups B1: 57%, B2: 29%, compared to initial values. The reduction of sera IFN-g in subgroup A1 continued until day 11, and in subgroup B1 until day 14, with small oscillations. After that, there was an increase of serum IFN-g concentrations in both subgroups, but mean concentrations measured on day 28 were lower when compared to initial concentrations. In our research we did not register statistically significant differences in IFN-g concentrations between sera of different subgroups recieving different doses of irradiation.
Rats recieving a single radiation dose of 4 or 6 Gy that were treated with bovine thymus extract, had an increase of IFN-g levels in sera by day 7 in both subgroups and this trend continued until day 28 of the experiment. The mean concentrations registered for both subgroups at the end of the experiment were higher than pre-radiation values and during the first days after irradiation. The difference was statistically highly significant (p £ 0.01) in subgroup A1 and significant (p £ 0.05) in subgroup B2.
Analyzing the mean concentrations of IFN-g in subgroups treated with bovine thymus extract and groups that did not recieve this treatment, on days 7 and 11 we registered statistically significant differences in group A (p £ 0.05) and highly significant difference (p £ 0.01) on day 28 (Table 1 ). In group B we noticed highly significant differences (p £ 0.01) on day 14 between subgroups B1 and B2, and on day 21 and 28 the difference was significant at the level of p £ 0.05. Analyzing the mean concentrations of IFN-g in sera of rats recieving different doses of ionizing radiation we found no statistical significance between subgroups A1 and B1 and A2 and B2.
Skin hyper-reactivity to PHA On day 7, after rat irradiation with 4 or 6 Gy, there was a decrease of skin hypersensitivity to PHA. In subgroups A1 and B1 we demonstrated a lower level of reactivity compared to control values at the begining of the experiment (p £ 0.01) (Figure 3 ). At the second mesurement, on day 14, in both subgroups there was an increase of skin reactivity and this increasing trend continued through days 21 and 28. During the experiment there was no statistically significant difference in skin reactivity to PHA between subgroups that were not treated with bovine thymus extract.
In the experimental group A, on day 7, we noted statistically highly significant differences (p £ 0.01) between treated and not treated groups of rats (A1 and A2), as shown in Table 2 . Following that, on day 14, the differences were not significantly different. Statistically significant differences in CBHR (p £ 0.05) between these groups were found again on days 21 and 28. In the second experimental group (B) statistically significant differences (p £ 0.05) were found on day 14 between groups B1 and B2 and these differences were maintained until the end of the experiment. In rats that were not treated with bovine thymus extract there were no significant differences between mean values of this test. In rats that were treated with bovine thymus extract after irradiation with 4 or 6 Gy, there were highly significant (p £ 0.01) differences on day 7 and statistically significant (p £ 0.05) differences on day 21.
ATTx humoral immune response
After a single irradiation of experimental animals with 4 or 6 Gy, all rats from experimental groups A and B had increased sera concentrations of ATTx on the day 7, as a result of primary antitetanus vaccination (Figure 4 ). The differences in sera ATTx values were statistically highly significant (p £ 0.001) when compared to pre-irradiation and pre-vaccination concentrations. In the experimental group C, in which animals were not vaccinated, ATTx concentrations were generally on the low level and slightly decreased after irradiation, but without statistical significance ( Figure 5) .
The highest mean concentrations of ATTx were recorded in animals irradiated with 4 Gy and treated with thymus extract. Moreover we found a marked increase of antibody concentrations in both experimental groups especially on day 21 following revaccination on day 14. At the end of the experiment, on day 28, the ATTx concentrations in subgroups A1 and B1 were significantly higher (p £ 0.001) than at the beginning of the experiment or at day 7 after primary vaccination (Table 3) . Analyzing the concentrations of antibodies to tetanus toxoid in sera of animals from experimental subgroups A1 and B1 which received different radiation doses, we were able to demonstrate only small differences: antibody concentrations were higher in animals receiving smaller irradiation doses. These differences were not statistically significant (Table 3) , except on day 21 (p £ 0.05).
Rats receiving 4 or 6 Gy and treated with thymic extract had a gradual increase of ATTx concentrations beginning on day 7 until the end of the experiment. Analyzing the mean sera concentrations of ATTx in treated rats, only in the experimental group A (A1 and A2) we noted statistically highly significant (p £ 0.001) differences in favor of the subgroup A1 from day 14 until the end of the experiment. Comparing the mean concentrations of sera ATTx in rats receiving different radiation doses (A2, B2), on day 7 there was a significantly higher concentration in subgroup A2 and this difference was maintained until the end of the experiment. At days 14 and 28 the differences were highly significant (p £ 0.01).
The positive effect of bovine thymus extract was also evident in the control group K2. In this group, on day 28, the difference in ATTx concentrations was statistically highly significant (p £ 0.001) in comparison to the control group K1. In the third group (K3) in which experimental animals were not vaccinated (or revaccinated) with antitetanus vaccine there were no concentration variations of ATTx during the experiment (Table 2) . DISCUSSION The results of this study indicate that the negative effects of X ray irradiation on the immune response can be reduced by bovine thymus extract acting as an immunostimulator.
The changes in IL-2 concentrations because of radiation are caused by thymus damage and thymocyte apoptosis. The extent of the damage and apoptosis depend on the received quantity of radiation (Adachi et al., 2005;  Mizutani et al., 2002) . IL-2 synthesis takes place in T cells, and they are the first ones to disappear in the damaged thymus. It is clear that the concentration of this interleukin decreases in the first days after radiation. After normal cellularity of the thymus is regained gradually, after day 7 after irradiation, there is a gradual increase of IL-2 concentrations in the sera.
After a single irradiation of rats in a dose of 6 Gy, Mizuni et al. (2002) registered high numbers of apoptotic thymocytes in the thymus cortex. At the same time, they registered a decrease of serum IL-2 to a lesser extent than in our experiment. After that, from experimental day 5, they found a diminishing number of apoptotic cells and a gradual increase of the number of thymocytes in the cortex. The same author demonstrated an increased macrophage activity because of the removal of apoptotic cells and also an increase of cytokines such as IL-2 and INF-g. In further measurements, Mizutani et al. (2002) did not find significant changes in IL-2 concentrations in the sera of irradiated rats. Adachi et al. (2005) investigated changes in the thymus of rats irradiated with 8 Gy and determined the concentration of IL-2 in their sera. On day 3 after irradiation, they registered a slight increase in the concentration of IL-2 followed by a rapid decrease after day 5 to day 14. A statistically significant increase was registered on day 21, after which, on day 28, the levels of IL-2 return to preirradiation values. The authors connect this dynamics to changes in the thymus, as IL-2 is synthesized in activated young thymocytes. This irradiation dose lead to greater damage in the thymus so that recovery was prolonged and a statistically significant concentration increase was achieved only by day 21. In our study, in rats receiving dose of 6 Gy of radiation, a significant increase of IL-2 concentrations was reached on day 18.
A positive effect and a better cellular response in rats treted with the bovine thymus extract were demonstrated by Jankovic and Maric (1988). They found that, in rats, in which the thymus was surgically removed, bovine thymus extract improves the cellular immune response. Goldstein et al., (1978) found that in mice with genetic thymus aplasia, bovine thymus extract was beneficial on lymphokine production as well as on T cell and NK cell functions. Fattah et al. (1999) studied the effect of bovine thymus extract on chicken. They noticed an improvement of the cellular immune response caused by the increase in T lymphocyte numbers and IL-2 concentrations.
Numerous authors described the favorable effect of bovine thymus extracts on IL-2 production in vitro in immunodefficient patients. Ben-Efraim et al. (1999) , Grumberg et al. (1997) and Schulye-Forster (1997) showed that bovine thymus extract increases the cytotoxic effect of NK cells activated through IL-2 on tumor cells. Bovine thymus extract increased the secretion of IL-2 and also the expression of IL-2 receptors on activated T cells.
It is well documented that different immunodefficiences in humans request different immunostimulants. Frega et al. (1994) and Skomicki et al. (1994) investigated the effect of bovine thymus extracts in HIV positive individuals. They found that, in vitro, these extracts significantly increase IL-2 production in both infected and non-infected patients. This is in accordance with our results because we were also able to demonstrate that in sera in non-irradiated (control) group of rats an increase of IL-2 was clearly evident. However, unlike from our findings, IL-2 in immunodefficient humans never reaches the values of the control groups. In our study rats irradiated with 4 Gy had IL-2 levels on day 28 similar to those in the control group that also received the thymic extract. Rats that received 6 Gy of radiation had IL-2 levels inferior to 50% of those in the control group and also compared to the group receiving 4 Gy. Based on these data, we may conclude that the level of IL-2 depends on the degree of immunodeficiency.
The changes in IFN-g concentrations in sera originate from thymus damage and thymocyte apoptosis due to irradiation. It has already been stated that dose dependent radiation damages the thymus and leads to thymocyte apoptosis (Adachi et al., 2005; Mizutani et al., 2002) . IFN-g is synthesized in T cells (T H 1) and NK cells and they are the first to disappear in the damaged thymus, thus the concentration of this interferon is reduced in the first days after irradiation. After day 7, with thymus recovery accompanied by normal cellularity, there is a gradual increase in IFN-g concentration in the serum. The results obtained by Adachi et al., (2005) are in agreement with our results. In their experiment, after a single dose irradiation of rats, there was a moderate decrease of IFN-g concentrations in sera. This decrease was maintained until day 11 of the experiment followed by statistically significant increase in IFN-g sera concentrations. On days 21 and 28 we noted a decrease of mean IFN-g concentrations. The obtained values were lower than before irradiation and this result was interpreted as a radiation effect on the thymus and the time needed for complete recovery and renewal of normal cellularity in irradiated individuals. Mizutani et al. (2002) registered a decrease of mean concentrations of IFN-g in sera of subletally irradiated rats. They also reported an increase of IFN-g concentrations that was statistically highly significant (p £ 0.01) following administration of proinflamatory cytokines on days 5 and 7.
There are few records about the effects of thymus extract on the immune status of animals and humans. The effects of bovine thymus extract treatment on the cellular immune response in chicken, including IFN-g, were studied by Fattah et al. (1990) . The authors found an improvement of the cellular immune response because of an increase of T lymphocyte counts and IFN-g concentration in sera. In vitro experiments showed that different extracts or extract fractions of the bovine thymus had a positive effect on T cells and production of IFN-g, as well as other factors of the immune cellular response. (Ben-Efraim et al., 1999; Grunberg et al., 1997; Schulze-Forster, 1997). In our recent study we were able to demonstrate that treatment of irradiated Wistar rats with thymic extract, resulted in a significant impovement of hematological parameter values that may be associated with cytokine production (Jovanovi} et al., 2006) .
Cutaneous hypersensitivity testing was used by numerous authors as an indicator of cellular immune response. In rats that received, after immunosuppression, different preparations of bovine thymus extracts or their fractions, a higher level of cutaneous hypersensitivity was documented (Jankovic, 1992; Jankovic and Maric, 1988; Maric et al., 1991a).
Phytohemagglutinin was used in vitro conditions to control thymocyte proliferation in immunosuppressed individuals. Ominska-Domoratzka et al., (2002) in mice and Barboza et al. (2000) in dogs, followed the effects of bovine thymus extracts on the mitogenesis (proliferation) of T cells stimulated by PHA or Con A. In both studies authirs proved a positive effect of the bovine thymus extracts on the cellular immune response and T cell proliferation.
The level of antibodies after ionizing radiation depends on the radiation dose and the time interval between irradiation and antigen exposure. Mankindan and Price (1972) found an absence of the primary humoral immune response after antigen exposure in the first 24 hours. Stewart and Perez (1976) found suppression of the humoral immune response in mice recieving sublethal doses of radiation. The humoral immune response depends on the renewal of T and B cells. With lower radiation dosage, after a few days (7 -10) , there is a gradual increase in antibody concentrations (Sharp and Watkins, 1981) .
Ben The positive effect of bovine thymus extracts on the humoral immune response was also registered in chicken. Fattah et al. (1999) found a statistically significantly higher concentration of antibodies in chicken vaccinated against IBVD (Infectious Bursal Disease Virus) treated with bovine thymus extracts when compared to untreated controls.
Bovine thymus extracts have positive effects on human humoral immune responses. In elderly patients that were given bovine thymus extracts after antitetanus vaccination, the registered increase of antitetanus antibody concentrations was statistically significant when compared to untreated individuals and pre-experimental levels (Jankovic et al., 1988; Fagiolo et al., 1993) .
CONCLUSIONS
Based on the obtained data, it can be concluded that a single 4 or 6 Gy irradiation of rats with X rays, produces a decreased cellular and humoral immune response and a significant decrease in serum concentrations of IL-2, IFN-g and ATTx and decreased cutaneous hypersensibility to PHA. After administration of bovine thymus extracts every other day to irradiated rats, there was an increase of IL-2, IFN-g and ATTx serum concentrations and an increase in cutaneous hypersensibility to PHA. A statistically significant increase of these parameters
